Niagen Bioscience, Inc. (NAGE)

Niagen Bioscience Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 5, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	517	406	108	125	256	297
Market Cap Growth	-10.07%	277.18%	-14.15%	-50.96%	-14.02%	15.84%
Enterprise Value	455	377	85	117	226	284
Last Close Price	6.45	5.30	1.43	1.68	3.74	4.80
PE Ratio	27.46	47.50	-	-	-	-
Forward PE	28.20	50.28	-	-	-	-
PS Ratio	4.06	4.08	1.29	1.74	3.79	5.02
PB Ratio	7.29	8.81	3.78	4.37	8.06	18.11
P/TBV Ratio	7.33	8.88	3.85	4.48	8.29	19.39
P/FCF Ratio	24.43	33.99	15.45	-	-	-
P/OCF Ratio	24.13	33.54	15.13	-	-	-
EV/Sales Ratio	3.65	3.78	1.01	1.62	3.35	4.79
EV/EBITDA Ratio	22.68	44.12	-	-	-	-
EV/EBIT Ratio	23.60	48.76	-	-	-	-
EV/FCF Ratio	21.54	31.54	12.17	-	-	-
Debt / Equity Ratio	0.04	0.06	0.12	0.15	0.15	0.10
Debt / EBITDA Ratio	0.14	0.27	-	-	-	-
Debt / FCF Ratio	0.14	0.22	0.47	-	-	-
Asset Turnover	1.61	1.62	1.53	1.29	1.40	1.51
Inventory Turnover	3.07	3.21	2.25	2.07	2.05	2.07
Quick Ratio	3.23	2.96	1.57	1.61	1.89	1.17
Current Ratio	4.12	3.57	2.40	2.61	2.78	1.96
Return on Equity (ROE)	38.90%	22.94%	-17.29%	-54.77%	-112.68%	-108.09%
Return on Assets (ROA)	15.60%	7.84%	-6.42%	-20.81%	-35.18%	-31.57%
Return on Capital (ROIC)	21.74%	12.00%	-10.82%	-33.57%	-62.10%	-61.70%
Return on Capital Employed (ROCE)	25.60%	15.40%	-16.30%	-51.50%	-67.30%	-90.70%
Earnings Yield	3.95%	2.10%	-4.59%	-13.19%	-10.61%	-6.70%
FCF Yield	4.09%	2.94%	6.47%	-12.31%	-9.61%	-3.60%
Buyback Yield / Dilution	-10.80%	-4.19%	-7.54%	-3.79%	-10.02%	-7.03%

Updated Nov 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q